Загрузка...
Vimentin 3, the New Hope, Differentiating RCC versus Oncocytoma
Vimentin is currently used to differentiate between malignant renal carcinomas and benign oncocytomas. Recent reports showing Vimentin positive oncocytomas seriously question the validity of this present diagnostic approach. Vimentin 3 is a spliced variant and ends with a unique C-terminal ending af...
Сохранить в:
| Опубликовано в: : | Dis Markers |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Publishing Corporation
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4405285/ https://ncbi.nlm.nih.gov/pubmed/25944973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/368534 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|